DNY59 Topline Summary and Update ALX Oncology (NASDAQ:ALXO) is a cancer-focused biotech I've expressed deep skepticism in over the course of various articles, stating unequivocally that I did not feel that the risk to reward ratio was appropriate at the billion-plus market cap that the company was commanding as a phase 2 entity. They had generated compelling findings in their early trial readouts, but the CD47-based approach carries too much baggage for me to get too excited. Since then, the company's va ...

ALX Resources Corp. Receives Analytical Results from the Gibbons Creek Uranium Project, Athabasca Basin, SaskatchewanJune 13, 2024 7:30 AM EDT | Source: ALX Resources Corp.Vancouver, British Columbia--(Newsfile Corp. - June 13, 2024) - ALX Resources Corp. (TSXV: AL) (FSE: 6LLN) (OTC: ALXEF) ("ALX" or the "Company") is pleased to announce the results of the 2024 winter drilling program and upcoming summer 2024 exploration plans at its Gibbons Creek Uranium Project ("Gibbons Creek", or the "Proj ...

SOUTH SAN FRANCISCO, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), an immuno-oncology company developing therapies that block the CD47 immune checkpoint pathway, today announced that management will participate in the Jefferies Global Healthcare Conference. Details are as follows: Format: Fireside chat with analyst, Michael Yee and 1x1 Investor MeetingsDate: Wednesday, June 5, 2024 Time: 1:00 PM ET Location: New York, NY Webcast link: ...

Core Viewpoint - The article discusses the potential investment opportunities in high-yield dividend stocks that are currently out of favor with Wall Street analysts, suggesting that these stocks may be worth investigating for contrarian investors [1][2]. Group 1: High-Yield Dividend Stocks - Seven dividend-paying stocks with yields up to 12.9% are highlighted, all of which are disliked by Wall Street analysts, indicating a potential contrarian investment opportunity [2]. - Xerox (XRX) offers a 7.2% yield, but its dividend has remained stagnant at $0.25 per share since 2017, reflecting a lack of growth and a prolonged downtrend in stock value, losing 25% in 2024 [3]. - Western Union (WU) has a 7.1% yield and has struggled against competitors, with a frozen dividend for several years. Despite a challenging outlook, shares have increased by 25% from spring 2023 lows, and the company is showing signs of progress with its "Evolve 2025" initiative [4][5]. - Alexander's (ALX) is an office REIT with an 8.3% yield, which has seen its stock value drop significantly due to COVID-19. The company has improved its funds from operations (FFO) coverage in Q1 2024, indicating potential recovery [6][7]. - Peakstone Realty Trust (PKST) has a 6.0% yield and has faced a nearly 60% decline since going public in April 2023. The company is repositioning its portfolio, which may improve its long-term prospects [8][9]. - National Storage Affiliates Trust (NSA) also has a 6.0% yield and has been affected by high home prices and interest rates. However, its dividend is well-covered at 89% of estimated 2024 FFO, and stock prices have been gradually improving [10]. - Buckle (BKE) offers a 10.0% yield but has a bearish analyst sentiment with one Hold and one Sell. Despite weaker operations, the company is expected to resume profit growth next fiscal year [11]. - Prospect Capital (PSEC) has a 12.9% yield but a poor track record with multiple dividend cuts. It trades at a significant discount to NAV, indicating deep value pricing despite analyst pessimism [12].

分组1 - Alexander's reported quarterly funds from operations (FFO) of $4.98 per share, missing the Zacks Consensus Estimate of $6.41 per share, and showing an increase from $3.63 per share a year ago, resulting in an FFO surprise of -22.31% [1] - The company posted revenues of $61.4 million for the quarter ended March 2024, missing the Zacks Consensus Estimate by 13.40%, compared to year-ago revenues of $52.94 million [1] - Over the last four quarters, Alexander's has surpassed consensus FFO estimates two times and topped consensus revenue estimates three times [1] 分组2 - The stock has added about 0.1% since the beginning of the year, underperforming the S&P 500's gain of 7.5% [2] - The current consensus FFO estimate for the coming quarter is $2.87 on $54.9 million in revenues, and for the current fiscal year, it is $14.86 on $235.5 million in revenues [4] - The Zacks Industry Rank for REIT and Equity Trust - Other is currently in the top 40% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [4]

Core Insights - Alexander's, Inc. reported a net income of $16.1 million, or $3.14 per diluted share, for the quarter ended March 31, 2024, an increase from $11.2 million, or $2.19 per diluted share, for the same quarter in 2023 [1][3] - Funds from operations (FFO) for the quarter was $25.5 million, or $4.98 per diluted share, compared to $18.6 million, or $3.63 per diluted share, for the quarter ended March 31, 2023 [1][3] - The company operates as a real estate investment trust (REIT) with five properties located in New York City [1] Financial Performance - Revenues for the quarter ended March 31, 2024, were $61.4 million, up from $52.9 million in the same quarter of 2023 [3][4] - The weighted average shares outstanding for basic and diluted calculations were 5,130,678 for both 2024 and 2023 [3][4] - Depreciation and amortization of real property for the quarter was $9.4 million, compared to $7.4 million in the previous year [4]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark one) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2024 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission File Number: 001-06064 ALEXANDERS INC (Exact name of registrant as specified in its charter) Delaware 51-0100517 | --- | --- | |-------------- ...

NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- Alexander's, Inc. today announced an 11-year lease extension agreement with Bloomberg LP which will begin at the expiration of the existing lease in 2029, continuing a long-standing headquarters presence at 731 Lexington Avenue through 2040. Bloomberg, which relocated its global headquarters to the tower upon its completion, will continue to occupy all 946,815 square feet of office space in the building. The company's headquarters at 731 Lexington remains its large ...

PARAMUS, N.J., April 25, 2024 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE:ALX) today announced that it will file its quarterly report on Form 10-Q for the quarter ended March 31, 2024 with the U.S. Securities and Exchange Commission and issue its first quarter earnings release on Monday, May 6, 2024, before the New York Stock Exchange opens. Vornado Realty Trust (NYSE:VNO), the manager which conducts Alexander's operations, announced it will host its quarterly earnings conference call and an audio webcast o ...

PARAMUS, N.J., April 25, 2024 (GLOBE NEWSWIRE) -- Alexander’s, Inc. (NYSE: ALX) today announced that it will file its quarterly report on Form 10-Q for the quarter ended March 31, 2024 with the U.S. Securities and Exchange Commission and issue its first quarter earnings release on Monday, May 6, 2024, before the New York Stock Exchange opens. Vornado Realty Trust (NYSE: VNO), the manager which conducts Alexander’s operations, announced it will host its quarterly earnings conference call and an audio webcast ...